No left-side outlet ran this
← All coverage gaps
2026-09-22 13:47
Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs
50%50%
2 outlets · Left 0 · Center 1 · Right 1
How each side titled it
Washington ExaminerLean right
Novo Nordisk sued over weight-loss drug spin. Now it’s doing the exact same thing
Each wing's outermost outlet, headline quoted verbatim - framing shows clearest at the edges. Center outlets appear with every other headline below.
Who got there first
each line: one outlet's first article — above the track left · below right · across center
First reported by Reuters (Center); 2 outlets over 32h.
Reuters · +32h Washington Examiner
What each side is saying
- ReutersCenter
Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs Reuters
Read at reuters.com → - Washington ExaminerLean right
Novo Nordisk and Eli Lilly are battling for dominance in one of medicine’s largest and fastest-growing markets: drugs for obesity and weight loss. On Monday, Novo announced encouraging results for its experimental drug CagriSema.
Read at washingtonexaminer.com →
Each blurb is the outlet's own feed summary, quoted unedited. Nothing here is generated.
2 articles, newest first · filter by side
location
Every headline that clustered into this story, newest first. Links go straight to the publisher - no article text is stored here, and the one image is an unmodified copy of the publisher's own thumbnail.